CDR
Study: Empower Ontario pharmacists to do more
Ontario’s health system could save at least $143 million (Canadian) over the next five years by making better use of pharmacist capabilities in five key practice areas, a study commissioned by the Ontario Pharmacists’ Association (OPA) found.
NACDS senators Rx abuse
NACDS Backs Senators’ Call to Review Prescription Drug Abuse, Patient Care Strategies March 5, 2013 Sens. Boxer, Coburn lead effort urging GAO to focus on health, enforcement coordination Arlington, Va. – The National Association of Chain Drug Stores (NACDS) supported a bipartisan request by U.S.
Colgate-Palmolive exec joins FGX International as CEO
FGX International has hired veteran consumer products executive César Melo as chief executive officer. César Melo The eyewear designer and marketer said Melo, who took the helm as CEO this week, succeeds current chief executive Alec Taylor, who is retiring after seven and a half years at FGX.
Bartell Drugs gets set for Health and Beauty Event
This weekend Bartell Drugs will kick off its Health and Beauty Event, where it will serve up a range of health and beauty aids samples and services to attendees at select stores.
L&R closes SAJ Distributor acquisition from Walgreens
L&R Distributors Inc. has finalized its deal to buy SAJ Distributors and the Select Brand private-label line from Walgreen Co. L&R said Tuesday that it will operate the current SAJ Distribution Center and offices in Pine Bluff, Ark.
Nexafed to hit shelves at Kerr Drug
Nexafed, a pseudoephedrine nasal decongestant designed to thwart makers of methamphetamine, is making its chain drug store debut at Kerr Drug. Acura Pharmaceuticals Inc.
Pfizer gets reissue patent for Celebrex, sues generics makers
Pfizer Inc. has been granted a reissue patent from United States Patent & Trademark Office for methods of treating osteoarthritis and other approved conditions with celecoxib, the active ingredient in Celebrex. The reissue patent is slated to expire on Dec.
Kerr Drug, Walgreens cited for MTM excellence
Kerr Drug and Walgreens were recognized for excellence in medication therapy management (MTM) services by OutcomesMTM. The MTM solution provider said Tuesday named Walgreens as the Top Large Pharmacy Chain and Kerr Drug as the Top Regional Pharmacy Chain for their MTM efforts and programs.
Pharmacy advocates primed for RxImpact Day
About 300 community pharmacy advocates from 37 states will assemble in Washington, D.C., next week for the National Association of Chain Drug Stores RxImpact Day on Capitol Hill.
February same-store sales dip at Walgreens
Introductions of lower-priced generic drugs contributed to a decline in comparable-store sales at Walgreen Co. in February. Walgreens said Tuesday that comp-store sales edged down 0.6% in February, with new generics negatively impacting results by 3.7 percentage points.
CVS Project Health gets under way
To help promote preventive care, CVS/pharmacy has launched its annual Project Health wellness campaign, which this year is slated to deliver more than $15 million of free health screenings to multicultural communities nationwide.
NACDS: Pharmacists can help improve care in Medicare, Medicaid
The National Association of Chain Drug Stores has urged Senate leaders to advance policies aimed at improving care for Medicare and Medicaid beneficiaries. NACDS said Friday that it submitted comments for a Feb.
More Rite Aid stores offer ‘virtual clinic’
With people seeking more convenient and affordable health care options, Rite Aid Corp. is pushing ahead with a "virtual clinic" offering.
London Drugs clinics to feature skin cholesterol test
Early next month, London Drugs aims to make available at all of its pharmacies a non-invasive cholesterol test that can help customers evaluate their risk for coronary artery disease (CAD) or heart disease. The western Canada drug chain said Thursday that on March 4 it plans to roll out the PreVu
GAO urged to review reimbursement cuts for diabetes supplies
The National Community Pharmacists Association has applauded lawmakers’ push for the Government Accountability Office (GAO) to review the impact of planned reductions in reimbursement for diabetes test supplies (DTS) provided to Medicare beneficiaries by community pharmacies. NCPA said that Reps.